Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Non-alcoholic fatty liver disease

Page Path

HOME
TOPICS
Non-alcoholic fatty liver disease

Original Article

Effects of different exercise modalities on novel hepatic steatosis indices in overweight women with type 2 diabetes

Ebrahim Banitalebi, Mohammad Faramarzi, Samira Nasiri, Majid Mardaniyan, Vahid Rabiee

Clin Mol Hepatol. 2019;25(3):294-304. Published online May 30, 2019

DOI: https://doi.org/10.3350/cmh.2018.0086

View: 7280 Download: 258 Web of Science: 13 Crossref: 17

Review

Recent research trends and updates on nonalcoholic fatty liver disease

Jeong-Ju Yoo, Won Kim, Moon Young Kim, Dae Won Jun, Sang Gyune Kim, Jong-Eun Yeon, Jin Woo Lee, Yong Kyun Cho, Sang Hoon Park, Joo Hyun Sohn

Clin Mol Hepatol. 2019;25(1):1-11. Published online August 8, 2018

DOI: https://doi.org/10.3350/cmh.2018.0037

View: 18935 Download: 721 Web of Science: 70 Crossref: 66

Original Article

The Association of leptin with severity of non-alcoholic fatty liver disease: A population-based study

Laura Rotundo, Alana Persaud, Mirela Feurdean, Sushil Ahlawat, Hyun-seok Kim

Clin Mol Hepatol. 2018;24(4):392-401. Published online August 2, 2018

DOI: https://doi.org/10.3350/cmh.2018.0011

View: 12381 Download: 239 Web of Science: 44 Crossref: 43

Combined effects of synbiotic and sitagliptin versus sitagliptin alone in patients with nonalcoholic fatty liver disease

Saba Sayari, Hassan Neishaboori, Maryam Jameshorani

Clin Mol Hepatol. 2018;24(3):331-338. Published online June 12, 2018

DOI: https://doi.org/10.3350/cmh.2018.0006

View: 8543 Download: 183 Web of Science: 31 Crossref: 35

Editorial

Combination of synbiotic and sitagliptin in nonalcoholic fatty liver disease: Is it better than sitagliptin alone?

Yong Kyun Cho

Clin Mol Hepatol. 2018;24(3):299-301. Published online September 7, 2018

DOI: https://doi.org/10.3350/cmh.2018.1006

View: 5834 Download: 106

Original Article

Picroside II attenuates fatty acid accumulation in HepG2 cells via modulation of fatty acid uptake and synthesis

Hiteshi Dhami-Shah, Rama Vaidya, Shobha Udipi, Srividhya Raghavan, Shiny Abhijit, Viswanathan Mohan, Muthuswamy Balasubramanyam, Ashok Vaidya

Clin Mol Hepatol. 2018;24(1):77-87. Published online December 19, 2017

DOI: https://doi.org/10.3350/cmh.2017.0039

View: 14926 Download: 627 Web of Science: 20 Crossref: 18

Serum matrix metalloproteinase-1 level represents disease activity as opposed to fibrosis in patients with histologically proven nonalcoholic steatohepatitis

Wataru Ando, Hiroaki Yokomori, Nobuhiro Tsutsui, Eigoro Yamanouchi, Yutaka Suzuki, Masaya Oda, Yutaka Inagaki, Katsuya Otori, Isao Okazaki

Clin Mol Hepatol. 2018;24(1):61-76. Published online November 20, 2017

DOI: https://doi.org/10.3350/cmh.2017.0030

View: 9470 Download: 176 Web of Science: 28 Crossref: 30

Review

Imaging evaluation of non-alcoholic fatty liver disease: focused on quantification

Dong Ho Lee

Clin Mol Hepatol. 2017;23(4):290-301. Published online October 10, 2017

DOI: https://doi.org/10.3350/cmh.2017.0042

View: 21445 Download: 481 Web of Science: 97 Crossref: 94

NASH Therapy: omega 3 supplementation, vitamin E, insulin sensitizers and statin drugs

Stephen Caldwell

Clin Mol Hepatol. 2017;23(2):103-108. Published online May 10, 2017

DOI: https://doi.org/10.3350/cmh.2017.0103

View: 12471 Download: 476 Web of Science: 32 Crossref: 32

Genetic predisposition in nonalcoholic fatty liver disease

Silvia Sookoian, Carlos J. Pirola

Clin Mol Hepatol. 2017;23(1):1-12. Published online March 9, 2017

DOI: https://doi.org/10.3350/cmh.2016.0109

View: 18141 Download: 608 Web of Science: 149 Crossref: 148

Non-alcoholic fatty liver diseases: update on the challenge of diagnosis and treatment

Hyunwoo Oh, Dae Won Jun, Waqar K Saeed, Mindie H Nguyen

Clin Mol Hepatol. 2016;22(3):327-335. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0049

View: 15699 Download: 534 Web of Science: 51 Crossref: 51

Original Article

The serum vitamin D level is inversely correlated with nonalcoholic fatty liver disease

Goh Eun Chung, Donghee Kim, Min-Sun Kwak, Jong In Yang, Jeong Yoon Yim, Seon Hee Lim, Mustafa Itani

Clin Mol Hepatol. 2016;22(1):146-151. Published online March 28, 2016

DOI: https://doi.org/10.3350/cmh.2016.22.1.146

View: 10295 Download: 140 Web of Science: 48 Crossref: 46

Effect of vitamin E in nonalcoholic fatty liver disease with metabolic syndrome: A propensity score-matched cohort study

Gi Hyun Kim, Jung Wha Chung, Jong Ho Lee, Kyeong Sam Ok, Eun Sun Jang, Jaihwan Kim, Cheol Min Shin, Young Soo Park, Jin-Hyeok Hwang, Sook-Hyang Jeong, Nayoung Kim, Dong Ho Lee, Jin-Wook Kim

Clin Mol Hepatol. 2015;21(4):379-386. Published online December 24, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.4.379

View: 12200 Download: 168 Web of Science: 15 Crossref: 11

Impact of hypothyroidism on the development of non-alcoholic fatty liver disease: A 4-year retrospective cohort study

Kil Woo Lee, Ki Bae Bang, Eun Jung Rhee, Heon Ju Kwon, Mi Yeon Lee, Yong Kyun Cho

Clin Mol Hepatol. 2015;21(4):372-378. Published online December 24, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.4.372

View: 9454 Download: 169 Web of Science: 47 Crossref: 47

Alcoholic fatty liver disease elevates estimated coronary heart disease risk to levels comparable with those of nonalcoholic fatty liver disease in the Korean population: a cross-sectional study

Hai Jin Kim, Jeong Han Kim, Won Hyeok Choe, So Young Kwon, Chang Hong Lee

Clin Mol Hepatol. 2014;20(2):154-161. Published online June 30, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.2.154

View: 7435 Download: 74 Web of Science: 7 Crossref: 7

Review

KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease

The Korean Association for the Study of the Liver (KASL)

Clin Mol Hepatol. 2013;19(4):325-348. Published online December 28, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.4.325

View: 13730 Download: 161 Crossref: 95

Original Article

Regional prevalence of non-alcoholic fatty liver disease in Seoul and Gyeonggi-do, Korea

Eun Haeng Jeong, Dae Won Jun, Yong Kyun Cho, Young Gil Choe, Seungho Ryu, Seung Min Lee, Eun Chul Jang

Clin Mol Hepatol. 2013;19(3):266-272. Published online September 30, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.3.266

View: 9426 Download: 99 Crossref: 67

Elevated red cell distribution width is associated with advanced fibrosis in NAFLD

Hwa Mok Kim, Bum Soo Kim, Yong Kyun Cho, Byung Ik Kim, Chong Il Sohn, Woo Kyu Jeon, Hong Joo Kim, Dong Il Park, Jung Ho Park, Kwan Joong Joo, Chang Joon Kim, Yong Sung Kim, Woon Je Heo, Won Seok Choi

Clin Mol Hepatol. 2013;19(3):258-265. Published online September 30, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.3.258

View: 9941 Download: 103 Crossref: 33

Editorial

Chasing after novel non-invasive markers to identify advanced fibrosis in NAFLD

Wonseok Kang, Seung Up Kim

Clin Mol Hepatol. 2013;19(3):255-257. Published online September 30, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.3.255

View: 5878 Download: 49 Crossref: 2

Review

Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis

Seung-Hoi Koo

Clin Mol Hepatol. 2013;19(3):210-215. Published online September 30, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.3.210

View: 14728 Download: 424 Crossref: 302

Original Article

The influence of waist circumference on insulin resistance and nonalcoholic fatty liver disease in apparently healthy Korean adults

Deok Yun Ju, Young Gil Choe, Yong Kyun Cho, Dong Suk Shin, Su Hyeon Yoo, Seo Hyoung Yim, Ji Yong Lee, Jung Ho Park, Hong Joo Kim, Dong Il Park, Chong Il Sohn, Woo Kyu Jeon, Byung Ik Kim

Clin Mol Hepatol. 2013;19(2):140-147. Published online June 27, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.2.140

View: 8128 Download: 74 Crossref: 26

Noninvasive predictors of nonalcoholic steatohepatitis in Korean patients with histologically proven nonalcoholic fatty liver disease

Young Seok Kim, Eun Sun Jung, Wonhee Hur, Si Hyun Bae, Jong Young Choi, Myeong Jun Song, Chang Wook Kim, Se Hyun Jo, Chang Don Lee, Young Sok Lee, Sang Wook Choi, Jin Mo Yang, Jeong Won Jang, Sang Gyune Kim, Seung Won Jung, Hee Kyung Kim, Hee Bok Chae, Seung Kew Yoon

Clin Mol Hepatol. 2013;19(2):120-130. Published online June 27, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.2.120

View: 10870 Download: 89 Crossref: 24

Editorial

Noninvasive markers: a double-edged sword that stratifies nonalcoholic steatohepatitis

Goh Eun Chung, Donghee Kim

Clin Mol Hepatol. 2013;19(2):116-119. Published online June 27, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.2.116

View: 6949 Download: 91

Case Report

Severe steatohepatitis with hepatic decompensation resulting from malnutrition after pancreaticoduodenectomy

Eun Hui Sim, Jung Hyun Kwon, Se Young Kim, Seung Min Jung, Lee-So Maeng, Jeong Won Jang, Kyu Won Chung

Clin Mol Hepatol. 2012;18(4):404-410. Published online December 21, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.4.404

View: 7502 Download: 86 Crossref: 15

Original Article

Serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease

Min-Sun Kwak, Donghee Kim, Goh Eun Chung, Seung Joo Kang, Min Jung Park, Yoon Jun Kim, Jung-Hwan Yoon, Hyo-Suk Lee

Clin Mol Hepatol. 2012;18(4):383-390. Published online December 21, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.4.383

View: 15186 Download: 125 Crossref: 81

Editorial

Elevated serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease

Byoung Kuk Jang

Clin Mol Hepatol. 2012;18(4):357-359. Published online December 21, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.4.357

View: 7128 Download: 90 Crossref: 26

Original Article

Enhanced A-FABP expression in visceral fat: potential contributor to the progression of NASH

Min Yong Yoon, Jun Mo Sung, Chang Seok Song, Won Young Lee, Eun Jung Rhee, Jun Ho Shin, Chang Hak Yoo, Seoung Wan Chae, Ja Yeon Kim, Wook Jin, Yong Kyun Cho

Clin Mol Hepatol. 2012;18(3):279-286. Published online September 25, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.3.279

View: 6991 Download: 74 Crossref: 11

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X

Impact Factor

14.0
First decision

09 Days

Publication after acceptance

03 Days

*Last 12 months

Viewed By 5505	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5405	MAFLD: How is it different from NAFLD?
Viewed By 5214	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 5094	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4725	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 176	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 113	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 108	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 90	MAFLD: How is it different from NAFLD?
Cited By 80	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach